ATRA Financials

Atara Biotherapeutics Inc - Financial statements & key metrics

Stock Price

$5.02

Market Cap

$43.10M

P/E Ratio

2.1

EPS

$2.57

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$128.94M

Gross Profit

Operating Income

Net Income

$-85.40M

EPS (Diluted)

$-11.41

Balance Sheet Highlights

Total Assets

$109.10M

Total Liabilities

$206.38M

Shareholders Equity

Cash & Equivalents

$25.03M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-68.72M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

61.8%

Operating Margin

-3.4%

Net Margin

0.3%

ROE

-20.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ATRA revenue?

ATRA's most recent quarterly revenue was $128.94M. Annual revenue can be calculated by summing the four most recent quarters.

Is ATRA profitable?

ATRA reported a loss of $85.40M in the most recent quarter. The net profit margin is 0.3%.

What is ATRA market cap?

ATRA has a market capitalization of $43.10M, making it a small-cap stock.

Does ATRA have debt?

View ATRA's balance sheet for debt information.

What is ATRA cash flow?

Cash flow data is available in the full financial statements.